×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
CD300a Antikörper
CD300A
Reaktivität: Human
WB, FACS
Wirt: Maus
Monoclonal
MEM-260
unconjugated
Produktdetails anti-CD300a Antikörper
(ausblenden)
Target
Alle CD300a (CD300A) Antikörper anzeigen
CD300a (CD300A)
Reaktivität
Alle Reaktivitäten für CD300a Antikörper
Human
Wirt
Alle Wirte für CD300a Antikörper
Maus
Klonalität
Alle Klonalitäten für CD300a Antikörper
Monoklonal
Konjugat
Alle Konjugate für CD300a Antikörper
Dieser CD300a Antikörper ist unkonjugiert
Applikation
Alle Applikationen für CD300a Antikörper
Western Blotting (WB), Flow Cytometry (FACS)
Spezifität
The antibody MEM-260 reacts with an extracellular epitope of CD300a, a 60 kDa leukocyte transmembrane glycoprotein expressed on human granulocytes, monocytes, neutrophils, NK cells, mast cells and dendritic cells, 25 % of circulating T cells and 15 % of circulating B cells.
Kreuzreaktivität (Details)
Human
Aufreinigung
Purified by protein-A affinity chromatography.
Reinheit
> 95 % (by SDS-PAGE)
Immunogen
HPB human acute lymphoid leukemia cell line
Klon
MEM-260
Isotyp
IgG1
Top Product
Discover our top product CD300A Primärantikörper
Alternativen
(anzeigen)
Anwendungsinformationen
(ausblenden)
Applikationshinweise
Flow cytometry: Recommended dilution: 2 μg/mL. Western blotting: Positive material: HPB cell line, negative material: JURKAT human cell line, RAJI human cell line, non-reducing conditions.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Konzentration
1 mg/mL
Buffer
Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Do not freeze.
Lagerung
4 °C
Informationen zur Lagerung
Store at 2-8°C. Do not freeze.
Details zu CD300a
(ausblenden)
Target
CD300a (CD300A)
Andere Bezeichnung
CD300a (CD300A Produkte )
Synonyme
CD300L-B1 antikoerper, CD300A antikoerper, clm8 antikoerper, B230315M08Rik antikoerper, Clm8 antikoerper, LMIR1 antikoerper, MAIR-I antikoerper, MAIR-Ia antikoerper, MMAC8 antikoerper, Pigr4 antikoerper, mcpir1 antikoerper, CLM-8 antikoerper, CMRF-35-H9 antikoerper, CMRF-35H antikoerper, CMRF35-H antikoerper, CMRF35-H9 antikoerper, CMRF35H antikoerper, CMRF35H9 antikoerper, IGSF12 antikoerper, IRC1 antikoerper, IRC1/IRC2 antikoerper, IRC2 antikoerper, IRp60 antikoerper, CD300 molecule like family member g antikoerper, CD300a molecule antikoerper, CMRF35-like molecule 8 antikoerper, CD300A molecule antikoerper, Cd300a molecule antikoerper, CD300LG antikoerper, CD300A antikoerper, LOC483289 antikoerper, clm8 antikoerper, Cd300a antikoerper
Hintergrund
CD300a molecule,CD300a (CMRF-35H, IRp60) is a non-MHC-specific inhibitory receptor of immunoglobulin superfamily, which contains three immunoreceptor tyrosine-based inhibitory motifs (ITIMs) that associate with SH2-containing phosphatases SHP-1 and SHP-2. CD300a is expressed on many cell types including T cells, NK cells, neutrophils, eosinophils or mast cells. Its triggering inhibits activating signals such as those of IL5, GM-CSF or eotaxin, as well as supresses mast cell degranulation or NK cell cytotoxic activity.,IRC, CLM-8, IGSF12, CMRF35H
Gen-ID
11314
UniProt
Q9UGN4
Pathways
Regulation of Leukocyte Mediated Immunity , Positive Regulation of Immune Effector Process
Zuletzt angesehen
(ausblenden)